| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NM0496-461 |
| P698 | PubMed publication ID | 8597958 |
| P2093 | author name string | Murray GI | |
| Melvin WT | |||
| O'Neil P | |||
| Duncan ME | |||
| Fothergill JE | |||
| P2860 | cites work | Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 |
| Immunohistochemistry of neurone specific enolase with gamma subunit specific anti-peptide monoclonal antibodies | Q39624348 | ||
| Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. | Q40791456 | ||
| Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours | Q44757884 | ||
| Biology of tumour metastasis | Q67537225 | ||
| A simple enzyme-linked immunosorbent assay (ELISA) for the neuron-specific γ isozyme of human enolase (NSE) using monoclonal antibodies raised against synthetic peptides corresponding to isozyme sequence differences | Q68205076 | ||
| Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors | Q68463043 | ||
| The relationship of collagenolytic activity to stage of human colorectal carcinoma | Q70182791 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal cancer | Q188874 |
| P304 | page(s) | 461-462 | |
| P577 | publication date | 1996-04-01 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer | |
| P478 | volume | 2 |
| Q79610831 | A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas |
| Q55409923 | A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter in endometrial carcinomas. |
| Q41895733 | A single step purification for autolytic zinc proteinases. |
| Q47365512 | Acetylshikonin suppresses invasion of Porphyromonas gingivalis‑infected YD10B oral cancer cells by modulating the interleukin-8/matrix metalloproteinase axis |
| Q38735033 | Anacyclus Pyrethrum Extract Exerts Anticancer Activities on the Human Colorectal Cancer Cell Line (HCT) by Targeting Apoptosis, Metastasis and Cell Cycle Arrest. |
| Q33473894 | Analysis of germline variants in CDH1, IGFBP3, MMP1, MMP3, STK15 and VEGF in familial and sporadic renal cell carcinoma |
| Q33193524 | Antibodies as therapeutic agents: vive la renaissance! |
| Q55463933 | Association of matrix metalloproteinase-1 gene polymorphism with glioblastoma multiforme in a northern Indian population. |
| Q74623001 | Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium |
| Q35225825 | BioXpress: an integrated RNA-seq-derived gene expression database for pan-cancer analysis. |
| Q37322052 | Blockade of PAR1 signaling with cell-penetrating pepducins inhibits Akt survival pathways in breast cancer cells and suppresses tumor survival and metastasis |
| Q40507455 | CXCL12-CXCR4 interactions modulate prostate cancer cell migration, metalloproteinase expression and invasion |
| Q35984652 | Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced |
| Q33818072 | Cell surface molecules and their prognostic values in assessing colorectal carcinomas |
| Q36614738 | Characterisation and protein expression profiling of annexins in colorectal cancer |
| Q37564785 | Characterisation of the oxysterol metabolising enzyme pathway in mismatch repair proficient and deficient colorectal cancer |
| Q34604748 | Clinical significance of matrix metalloproteinase-9 expression in esophageal squamous cell carcinoma |
| Q35104008 | Clinicopathological significance of stromal variables: angiogenesis, lymphangiogenesis, inflammatory infiltration, MMP and PINCH in colorectal carcinomas |
| Q36104060 | Colon cancer: prevalence, screening, gene expression and mutation, and risk factors and assessment |
| Q28240136 | Colorectal cancer: genetics of development and metastasis |
| Q34047563 | Colorectal cancer: how does it start? How does it metastasize? |
| Q35356264 | Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers |
| Q38222535 | Controlled release from recombinant polymers |
| Q36715291 | Correlations of polymorphisms in matrix metalloproteinase-1, -2, and -7 promoters to susceptibility to malignant gliomas |
| Q79387628 | Curative in situ ablation of colorectal liver metastases-experimental and clinical implementation |
| Q34589151 | Curcumin: from ancient medicine to current clinical trials. |
| Q37777391 | Current and emerging concepts in tumour metastasis |
| Q35753592 | Decreased mRNA expression of transcription factor forkhead box F2 is an indicator of poor prognosis in patients with resected esophageal squamous cell carcinoma |
| Q28478307 | Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells |
| Q34277292 | Diagnostic and prognostic tumor markers in the gastrointestinal tract. |
| Q33591457 | Differential expression of M3 muscarinic receptors in progressive colon neoplasia and metastasis |
| Q35597250 | Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid |
| Q30818159 | Distinct biological events generated by ECM proteolysis by two homologous collagenases |
| Q36166778 | EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer |
| Q47925738 | Effect of the expression of matrix metalloproteases and their tissue inhibitors on survival of patients with resectable colorectal cancer. |
| Q64269715 | Effects of varying radiation dosages on MMP1 expression, and MMP1 knockdown on the viability and migration of SW620 cells |
| Q40938141 | Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer |
| Q33789052 | Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells |
| Q36014448 | Expression of CD147, PCNA, VEGF, MMPs and their clinical significance in the giant cell tumor of bones. |
| Q73009012 | Expression of matrix metalloproteinase-1 in human colorectal carcinoma |
| Q42259299 | Expression of the serine protease inhibitor serpinA3 in human colorectal adenocarcinomas |
| Q44602463 | Fra‐1 targets the AP‐1 site/2G single nucleotide polymorphism (ETS site) in the MMP‐1 promoter |
| Q24670045 | Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor |
| Q39711491 | Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy |
| Q33264591 | Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma |
| Q35045577 | Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway |
| Q40862510 | Human keratinocyte cell lines differ in the expression of the collagenolytic matrix metalloproteinases-1,-8, and -13 and of TIMP-1. |
| Q34330943 | Human retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastase |
| Q37685419 | IL-1β, IL-8, and Matrix Metalloproteinases-1, -2, and -10 Are Enriched upon Monocyte-Breast Cancer Cell Cocultivation in a Matrigel-Based Three-Dimensional System |
| Q34469524 | IgG expression in human colorectal cancer and its relationship to cancer cell behaviors |
| Q81329143 | Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas |
| Q40044969 | Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation |
| Q40626972 | Inhibition of MMP-1 expression by antisense RNA decreases invasiveness of human chondrosarcoma. |
| Q40082273 | Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture |
| Q38724705 | Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells |
| Q35746355 | Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter |
| Q39629370 | MMP-1-PAR1 axis mediates LPA-induced epithelial ovarian cancer (EOC) invasion |
| Q34581776 | MMP1 bimodal expression and differential response to inflammatory mediators is linked to promoter polymorphisms |
| Q33947759 | MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma |
| Q34457039 | Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis. |
| Q36097959 | Matrix metalloprotease-1a promotes tumorigenesis and metastasis |
| Q35586378 | Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer |
| Q36850412 | Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses |
| Q40901330 | Matrix metalloproteinase inhibitors in the treatment of cancer |
| Q73826631 | Matrix metalloproteinase inhibitors: how can we optimize their development? |
| Q38621634 | Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis |
| Q47327727 | Matrix metalloproteinase-1 expression in breast carcinoma: a marker for unfavorable prognosis. |
| Q47631180 | Matrix metalloproteinase-1 gene promoter polymorphism and risk of ovarian cancer |
| Q39704301 | Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours |
| Q36538338 | Matrix metalloproteinase-1 promotes prostate tumor growth and metastasis. |
| Q36508733 | Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells |
| Q84031941 | Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) in preoperative serum as independent prognostic markers in patients with colorectal cancer |
| Q78688144 | Matrix metalloproteinase-26 is expressed in human endometrium but not in endometrial carcinoma |
| Q42053210 | Matrix metalloproteinases (MMPs) in fresh human prostate tumour tissue and organ-cultured prostate tissue: levels of collagenolytic and gelatinolytic MMPs are low, variable and different in fresh tissue versus organ-cultured tissue |
| Q53000471 | Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer. |
| Q41239245 | Matrix metalloproteinases and the development of cancer |
| Q35353488 | Matrix metalloproteinases and their inhibitors in gastric cancer |
| Q80938331 | Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer |
| Q54649706 | Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma. |
| Q38107451 | Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets |
| Q41957800 | Matrix metalloproteinases in gastrointestinal cancer |
| Q79363986 | Matrix metalloproteinases in rectal mucosa, tumour and plasma: response after preoperative irradiation |
| Q41597461 | Matrix metalloproteinases. Novel targets for directed cancer therapy |
| Q74602356 | Matrix metalloproteinases: a multifunctional group of molecules |
| Q33692926 | Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications |
| Q38305585 | Metastatic ability of Drosophila tumors depends on MMP activity |
| Q35019702 | Mmp1a and Mmp1b are not functional orthologs to human MMP1 in cigarette smoke induced lung disease |
| Q53483201 | Mobilization of epithelial mesenchymal transition genes distinguishes active from inactive lesional tissue in patients with ulcerative colitis. |
| Q35031677 | Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation |
| Q33539986 | Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis |
| Q35566735 | Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells |
| Q37798870 | Nano to micro delivery systems: targeting angiogenesis in brain tumors |
| Q43890110 | Novel cyclopeptides for the design of MMP directed delivery devices: a novel smart delivery paradigm |
| Q37058474 | Optical tecnology developments in biomedicine: history, current and future |
| Q33888212 | Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic |
| Q28073129 | Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum |
| Q33946167 | Phage display of tissue inhibitor of metalloproteinases-2 (TIMP-2): identification of selective inhibitors of collagenase-1 (metalloproteinase 1 (MMP-1)) |
| Q34329984 | Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma |
| Q42756100 | Proteases as prognostic markers in cancer |
| Q37708490 | Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer |
| Q39234154 | Proteolysis in Helicobacter pylori-Induced Gastric Cancer |
| Q40794766 | Proteolysis in colorectal cancer |
| Q42095382 | Proteolysis in human breast and colorectal cancer |
| Q33275224 | Proteomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma |
| Q73687938 | Quantification of matrix metalloproteinase activity in plasma of patients enrolled in a BAY 12-9566 phase I study |
| Q34097985 | Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression. |
| Q30428013 | Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases |
| Q34335305 | Role of interstitial collagenase gene promoter polymorphism in the etiology of gastric cancer |
| Q37355071 | Serum markers of matrix turnover as predictors for the evolution of colorectal cancer metastasis under chemotherapy |
| Q46853773 | Serum matrix metalloproteinases and tympanosclerosis |
| Q42847300 | Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction |
| Q37260036 | Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. |
| Q44855281 | Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas |
| Q47272138 | Speckle-Type POZ Protein Down-Regulates Matrix Metalloproteinase 2 Expression via Sp1/PI3K/Akt Signaling Pathway in Colorectal Cancer |
| Q35167925 | Surrogate markers in antiangiogenesis clinical trials |
| Q42367521 | Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer. |
| Q39071510 | TGF-β, Bone Morphogenetic Protein, and Activin Signaling and the Tumor Microenvironment |
| Q52390843 | Targeting M3 Muscarinic Receptors for Colon Cancer Therapy. |
| Q37326414 | Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer |
| Q39854992 | Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide |
| Q43722831 | The association of matrix metalloproteinase-1 genetic polymorphism (-1607 1G>2G) with colorectal cancer: a meta-analysis |
| Q40169317 | The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice |
| Q36622489 | The clinical significance of MMP-1 expression in oesophageal carcinoma |
| Q36610051 | The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer |
| Q50971441 | The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance. |
| Q24313329 | The discoidin domain receptor tyrosine kinases are activated by collagen |
| Q33885041 | The integrated pathway of TGFβ/Snail with TNFα/NFκB may facilitate the tumor-stroma interaction in the EMT process and colorectal cancer prognosis |
| Q33693020 | The matrix metalloproteinases and their inhibitors in the treatment of pancreatic cancer. |
| Q53380355 | The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. |
| Q34503022 | The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model |
| Q36644626 | Tissue levels of active matrix metalloproteinase-2 and -9 in colorectal cancer. |
| Q38181431 | Tissue-based biomarkers predicting outcomes in metastatic colorectal cancer: a review. |
| Q28392041 | Tpl2 knockout keratinocytes have increased biomarkers for invasion and metastasis |
| Q33641532 | Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation |
| Q30747366 | Tumor targeting with a selective gelatinase inhibitor |
| Q36617345 | Tumour markers of prognosis in colorectal cancer |
| Q53348981 | Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. |
| Q64274115 | Tunable enzyme responses in amphiphilic nanoassemblies through alterations in the unimer-aggregate equilibrium |
| Q36078608 | Tyrosyl phosphorylated serine-threonine kinase PAK1 is a novel regulator of prolactin-dependent breast cancer cell motility and invasion |
| Q33809585 | Upregulation of tyrosine kinase TKT by the Epstein-Barr virus transactivator Zta |
| Q79103460 | Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patients |
| Q73037352 | [Clinical, pathological and molecular prognostic factors in colorectal carcinomas] |
| Q81755957 | [Current status of the prognostic value of molecular markers in patients with colorectal cancer and the prediction of response to adjuvant therapy] |
| Q42794991 | beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer |
| Q30453552 | p38 mitogen-activated protein kinase-dependent activation of protein phosphatases 1 and 2A inhibits MEK1 and MEK2 activity and collagenase 1 (MMP-1) gene expression |
| Q39634867 | p53 Dysfunction by Xeroderma Pigmentosum Group C Defects Enhance Lung Adenocarcinoma Metastasis via Increased Mmp1 Expression |
Search more.